AbbVie Inc. (ABBV) vs Gold (one troy ounce) (GOLD)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

Gold priced in U.S. dollars represents the market value of one troy ounce of gold. Gold is widely used as a store of value, reserve asset, jewelry input, and industrial material, and it often attracts demand during periods of inflation concern, currency weakness, or financial stress. Its price is influenced by real interest rates, central-bank buying, investor flows, mining supply, jewelry demand, and the strength of the U.S. dollar.